These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 5059801)

  • 41. Novel gastroretentive dosage forms: evaluation of gastroretentivity and its effect on riboflavin absorption in dogs.
    Klausner EA; Lavy E; Stepensky D; Friedman M; Hoffman A
    Pharm Res; 2002 Oct; 19(10):1516-23. PubMed ID: 12425470
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Studies on the inhibition of intestinal absoprtion of radioactive strontium. VI. Alginate degradation products as potent in vivo sequestering agents of radioactive strontium.
    Tanaka Y; Skoryna SC; Waldron-Edward D
    Can Med Assoc J; 1968 Jun; 98(25):1179-82. PubMed ID: 5657184
    [No Abstract]   [Full Text] [Related]  

  • 43. [Age, alginates and metabolism of calcium and strontium].
    Gruden N; Kostial K; Buben M
    Arh Hig Rada Toksikol; 1970; 21(1):27-33. PubMed ID: 5205533
    [No Abstract]   [Full Text] [Related]  

  • 44. The biological fate of riboflavin in mammals. A survey of literature and own investigations.
    Christensen S
    Acta Pharmacol Toxicol (Copenh); 1973; 32():3-72. PubMed ID: 4586598
    [No Abstract]   [Full Text] [Related]  

  • 45. Riboflavin-iron interactions with particular emphasis on the gastrointestinal tract.
    Powers HJ
    Proc Nutr Soc; 1995 Jul; 54(2):509-17. PubMed ID: 8524897
    [No Abstract]   [Full Text] [Related]  

  • 46. Riboflavin metabolism.
    Rivlin RS
    N Engl J Med; 1970 Aug; 283(9):463-72. PubMed ID: 4915004
    [No Abstract]   [Full Text] [Related]  

  • 47. Does aging affect the intestinal transport of riboflavin?
    Said HM; Hollander D
    Life Sci; 1985 Jan; 36(1):69-73. PubMed ID: 3965842
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Riboflavin deficiency and iron absorption in adult Gambian men.
    Fairweather-Tait SJ; Powers HJ; Minski MJ; Whitehead J; Downes R
    Ann Nutr Metab; 1992; 36(1):34-40. PubMed ID: 1590670
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Functional involvement of RFVT3/SLC52A3 in intestinal riboflavin absorption.
    Yoshimatsu H; Yonezawa A; Yao Y; Sugano K; Nakagawa S; Omura T; Matsubara K
    Am J Physiol Gastrointest Liver Physiol; 2014 Jan; 306(2):G102-10. PubMed ID: 24264046
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biopharmaceutic and pharmacokinetic studies following the oral administration of sodium salicylate in oily and aqueous vehicles to rabbit.
    Alhamami OM; Aljanabi NH; Shalan NM
    Int J Pharm; 2006 Mar; 311(1-2):63-8. PubMed ID: 16455214
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Impaired intestinal absorption of riboflavin in experimental uremia.
    Vaziri ND; Said HM; Hollander D; Barbari A; Patel N; Dang D; Kariger R
    Nephron; 1985; 41(1):26-9. PubMed ID: 4033840
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Studies on inhibition of intestinal absorption of radioactive strontium. IX. Relationship between biological activity and electron microscopic appearance of alginic acid components.
    Tanaka Y; Inoue S; Skoryna SC
    Can Med Assoc J; 1970 Sep; 103(5):484-6. PubMed ID: 5469618
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Daily ingestion of alginate reduces energy intake in free-living subjects.
    Paxman JR; Richardson JC; Dettmar PW; Corfe BM
    Appetite; 2008 Nov; 51(3):713-9. PubMed ID: 18655817
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Suppression of radioactive strontium absorption by sodium alginate in animals and human subjects.
    Gong YF; Huang ZJ; Qiang MY; Lan FX; Bai GA; Mao YX; Ma XP; Zhang FG
    Biomed Environ Sci; 1991 Sep; 4(3):273-82. PubMed ID: 1764217
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Improvement of absorption rate of indomethacin and reduction of stomach irritation by alginate dispersions.
    Shiraishi S; Imai T; Iwaoka D; Otagiri M
    J Pharm Pharmacol; 1991 Sep; 43(9):615-20. PubMed ID: 1685518
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Influence of formulation of enteric coated tablets on the bioavailability of the drug. 5th Part: Bioavailability of Riboflavin enteric coated tablets (author's transl)].
    Delporte JP; Jaminet F
    J Pharm Belg; 1976; 31(4):341-54. PubMed ID: 978382
    [No Abstract]   [Full Text] [Related]  

  • 57. Riboflavin nutritional status and absorption in oral contraceptive users and nonusers.
    Carrigan PJ; Machinist J; Kershner RP
    Am J Clin Nutr; 1979 Oct; 32(10):2047-51. PubMed ID: 484523
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Alginate/chitosan nanoparticles are effective for oral insulin delivery.
    Sarmento B; Ribeiro A; Veiga F; Sampaio P; Neufeld R; Ferreira D
    Pharm Res; 2007 Dec; 24(12):2198-206. PubMed ID: 17577641
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Development of an enteric nanoparticle of marine sulfated polysaccharide propylene glycol alginate sodium sulfate for oral administration: formulation design, pharmacokinetics and efficacy.
    Li P; Hao J; Li H; Guan H; Li C
    J Pharm Pharmacol; 2018 Jun; 70(6):740-748. PubMed ID: 29532471
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Controlling of systemic absorption of gliclazide through incorporation into alginate beads.
    Al-Kassas RS; Al-Gohary OM; Al-Faadhel MM
    Int J Pharm; 2007 Aug; 341(1-2):230-7. PubMed ID: 17507189
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.